Novo Nordisk's chief financial officer said, “We are advancing the company-wide transformation to achieve the DKK 8 billion cost savings target, which is now ahead of schedule.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.